Aberdeen Group
PRCT icon

Aberdeen Group’s Procept Biorobotics PRCT Stock Holding History

Aberdeen Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
66,807
-3,293
-5% -$82.4K ﹤0.01% 799
2026
Q1 		$1.75M Buy
70,100
+958
+1% +$27K ﹤0.01% 772
2025
Q4 		$2.18M Buy
69,142
+20,023
+41% +$664K ﹤0.01% 771
2025
Q3 		$1.75M Sell
49,119
-4,749
-9% -$217K ﹤0.01% 792
2025
Q2 		$3.06M Buy
53,868
+9,870
+22% +$558K 0.01% 745
2025
Q1 		$2.51M Sell
43,998
-26,279
-37% -$1.79M ﹤0.01% 744
2024
Q4 		$5.69M Sell
70,277
-7,081
-9% -$605K 0.01% 626
2024
Q3 		$6.24M Sell
77,358
-25,317
-25% -$1.8M 0.01% 615
2024
Q2 		$6.27M Sell
102,675
-2,032
-2% -$121K 0.01% 592
2024
Q1 		$5.17M Sell
104,707
-1,293
-1% -$61.5K 0.01% 663
2023
Q4 		$4.44M Sell
106,000
-3,944
-4% -$134K 0.01% 691
2023
Q3 		$3.61M Hold
109,944
– – 0.01% 607
2023
Q2 		$3.89M Hold
109,944
– – 0.01% 614
2023
Q1 		$3.12M Buy
109,944
+28,270
+35% +$997K 0.01% 657
2022
Q4 		$3.39M Buy
+81,674
New +$3.51M 0.01% 627

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aberdeen Group's PRCT Position: Q2 2026 in Review

Aberdeen Group reduced its Procept Biorobotics (PRCT) stake by 4.7% in Q2 2026, selling an estimated $82.4K and leaving 66,807 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Aberdeen Group first reported a position in PRCT in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.27M in Q2 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Aberdeen Group held 66,807 shares of Procept Biorobotics worth $1.51M as of Q2 2026.
  • Aberdeen Group sold 3,293 Procept Biorobotics shares in Q2 2026, an estimated $82.4K.
  • Procept Biorobotics made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #799 holding.
  • Aberdeen Group first reported a position in Procept Biorobotics in Q4 2022 and has held it in 15 quarters since.
  • Aberdeen Group's Procept Biorobotics position peaked at $6.27M in Q2 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.